IP Library › Granted Patent US 9,408,916
Granted Patent B2
US 9,408,916 · App. 14/491,813 · Granted Aug 9, 2016

Polymer films

Inventors: Gregory M. Cruise (Rancho Santa Margaria, CA); Gloria Hincapie (Tustin, CA); Clayton Harris (Tustin, CA); Yue Wu (Tustin, CA)
Assignee: MicroVention, Inc.
A61K47/32A61K9/0024A61L31/148A61L31/16C08F120/56C08F220/56C08F222/1006C08F222/385Y10T428/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,916
App. No.
14/491,813
Granted
Aug 9, 2016
Kind
B2
Abstract

Biodegradable, cross-linked polymer films and methods of making the same are described. The polymer films can be used for preventing adhesions following surgery and/or delivering therapeutic agents.

Claims (31)

1. A polymer film comprising:

at least one monomer including at least one functional group; and

at least one crosslinker selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate,

wherein a, b, c, d, e, and f are each independently 1-20;

wherein the polymer film has a thickness between about 40 μm and about 1,200 μm and is biodegradable.

2. The polymer film of claim 1 , wherein the polymer film has a shape selected from a circle, square, rectangle, triangle, ellipse, or pentagon.

3. The polymer film of claim 1 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

4. The polymer film of claim 1 , wherein the at least one monomer includes an ionizable functional group.

5. The polymer film of claim 4 , wherein the ionizable functional group is basic.

6. The polymer film of claim 4 , wherein the ionizable functional group is acidic.

7. The polymer film of claim 1 , wherein the at least one crosslinker includes at least two functional groups.

8. The polymer film of claim 1 , wherein the crosslinker includes at least one linkage susceptible to degradation through hydrolysis or enzymatic action.

9. The polymer film of claim 8 , wherein the at least one linkage is an ester, a thioester, a carbonate, a carbamate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenase, a peptide cleavable by matrix elastase, a peptide cleavable by matrix cathepsin, or a combination thereof.

10. The polymer film of claim 9 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a carbamate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins.

11. The polymer film of claim 1 , wherein the polymer film is substantially degraded within about 6 months of implantation.

12. The polymer film of claim 1 , wherein the polymer film is substantially degraded within about 1 month of implantation.

13. The polymer film of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol.

14. The polymer film of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

15. A method of making a polymer film comprising:

reacting a prepolymer solution including at least one monomer including at least one functional group, at least one crosslinker susceptible to degradation, and an initiator; and

forming the polymer film, wherein the polymer film has a thickness between about 40 μm and about 1,200 μm,

wherein the at least one crosslinker is selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate,

wherein a, b, c, d, e, and f are each independently 1-20.

16. The method of claim 15 , wherein the film is formed between two plates including at least one spacer.

17. The method of claim 15 , wherein the initiator is N,N,N′,N′-tetramethylethylenediamine.

18. The method of claim 15 , wherein the polymer film has a shape selected from a circle, square, rectangle, triangle, ellipse, or pentagon.

19. The method of claim 15 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

20. The method of claim 15 , wherein the polymer film is biodegradable.

21. The method of claim 20 , wherein the polymer film is substantially degraded within about 1 month of implantation.

22. The method of claim 20 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol.

23. The method of claim 20 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2016
From: HARRIS, CLAYTON
To: MICROVENTION, INC.
Reel/Frame 038092/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2016
From: CRUISE, GREGORY M.; HINCAPIE, GLORIA; WU, YUE
To: MICROVENTION, INC.
Reel/Frame 038093/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2014
From: CRUISE, GREGORY M.; HINCAPIE, GLORIA; HARRIS, CLAYTON; WU, YUE
To: MICROVENTION, INC.
Reel/Frame 034265/0776 →
Continuity (2)
Provisional Application 61880029 · Sep 19, 2013
Related Publication 20150079328A1 · Mar 19, 2015